|
|
| |
Simoa技术原理 | |
| |
| |
| |
| |
爆款产品 | |
超灵敏细胞因子多重检测 | |
超灵敏细胞因子多重检测试剂盒专为常见的超低丰度细胞因子检测而开发,每次实验可实现多个指标的检测,在节省样本的同时,保持了超高灵敏度和数据稳定性。Run间、Run内;仪器间、Lot号间的CV基本小于10%。线性稀释和回收率实验,上下浮动也能小于20% 。 | |
超灵敏单个因子检测 | |
Simoa试剂盒还可以实现单个细胞因子的检测,多元化地满足不同的研究需求。在常见和稀有细胞因子检测方面Simoa试剂盒均有广泛覆盖,具体如下表: | |
Simoa技术优势 | |
| |
David Yeung [1]等研究人员对比了大多数超敏蛋白质检测技术对于IL-2、IL-6、IL-17A、TNF-α等低丰度炎症因子的检测情况,发现Sioma技术无论在灵敏度还是在数据重现性上,相比其他技术均具有显著优势。因此,Simoa技术适合用于低丰度炎症因子检测。 | |
FEAD: Frequency of endogenous analyte detection | |
检测指标 | |
华盈生物全力打造抗体芯片、Luminex和Simoa技术的联合检测平台,全面解决炎症因子的筛选与低丰度检出问题,为临床标志物研究、药物评价、疾病机理等生物医学研究提供系统性解决方案。 | |
相关文献 | |
1. Skaug B, et al. Type I interferon dysregulation in Systemic Sclerosis. Cytokine. 2019 Jan 23. pii: S1043-4666(19)30006-7. 3.078 2. Fleischmann RM, et al. A Phase 2 Trial of Lutikizumab, an Anti-Interleukin 1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis. Arthritis Rheumatol. 2019 Jan 17. 9.002 3. Saxena A, et al. Ultrasensitive Quantification of Cytokine Proteins in Single Lymphocytes From Human Blood Following ex-vivo Stimulation. Front Immunol. 2018 Oct 23; 9: 2462. 4.716 4. Webster B, et al. Plasmacytoid dendritic cells control dengue and Chikungunya virus infections via IRF7-regulated interferon responses. Elife. 2018 Jun 19; 7. pii: e34273. 7.551 5. Timothy Garvey W, et al. Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes. Metabolism: clinical and experimental. 2018. 5.963 6. Forsberg A, et al. The immune response of the human brain to abdominal surgery. Ann Neurol. 2017;81:572-582. 10.25 7. Gill J, et al. Moderate blast exposure results in increased IL-6 and TNFalpha in peripheral blood. Brain, behavior, and immunity. 2017;65:90-94. 6.306 8. Larsen M, et al. Elevated Neopterin Levels Predict Early Death in Older Hip-fracture Patients. EBioMedicine. 2017. 6.183 9. Rodero MP, et al. Detection of interferon alpha protein reveals differential levels and cellular sources in disease. J Exp Med. 2017;214:1547-1555. 10.79 10. Salio M, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017 Oct 15;199(8):2631-2638. 4.539 11. Zanin-Zhorov A, et al. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10. Journal of immunology (Baltimore, Md : 1950). 2017;198:3809-3814. 4.539 |